Research Highlights

Nature Clinical Practice Cardiovascular Medicine (2005) 2, 5-6
doi:10.1038/ncpcardio0084  

Advances in infant heart transplantation

This article has no abstract so we have provided the first paragraph of the full text.

Transplantation of ABO-incompatible allografts is not generally feasible, except in some cases of kidney and liver transplantation in heavily immunosuppressed individuals. A new study by Fan et al., published in Nature Medicine, has demonstrated the development of B-cell tolerance to donor blood group A and B antigens in infants undergoing ABO-incompatible heart transplantation. This finding is the first illustration of intentional tolerance induction in human infants.

Full text of this article is available with one of the following:
  1. Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
  2. 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
  3. Site licence Learn more about institutional site licences

Current Subscribers

Please log in to access the full text article using the login box at the top of the page.



MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Transplantation tolerance: babies take the first step

Nature Medicine News and Views (01 Nov 2004)

Knocking out xenograft rejection

Nature Biotechnology Research News (01 Mar 2002)

Another step towards xenotransplantation

Nature Medicine News and Views (01 Dec 1995)

Liver transplants contribute to their own success

Nature Medicine News and Views (01 Feb 1996)

See all 7 matches for News And Views

Extra navigation

.